Saroglitazar
CAS: 495399-09-2
| 1 | Saroglitazar |
| 2 | Lipaglyn |
| 3 | saroglitazarum |
| 4 | E0YMX3S4JD |
| 5 | CHEBI:134708 |
Saroglitazar is a monocarboxylic acid that is (2S)-2-ethoxy-3-(p-ethoxyphenyl)propanoic acid in which one of the methyl hydrogens of the p-ethoxy substituent has been replaced by the nitrogen of 2-methyl-5-[4-(methylthio)phenyl]-1H-pyrrole. An agonist at the subtypes alpha and gamma of the peroxisome proliferator-activated receptor (PPAR) with predominant PPARalpha activity, it is used in the treatment of type 2 diabetes. It has a role as a hypoglycemic agent, a PPARalpha agonist and a PPARgamma agonist. It is a monocarboxylic acid, a member of pyrroles, an aromatic ether and a methyl sulfide.
| Molecular Formula | C25H29NO4S |
|---|---|
| Canonical SMILES | |
| Isomeric SMILES | |
| Molecular Weight | 439.6000 |
| InChIKey | MRWFZSLZNUJVQW-DEOSSOPVSA-N |
| InChI | InChI=1S/C25H29NO4S/c1-4-29-24(25(27)28)17-19-6-10-21(11-7-19)30-16-15-26-18(2)5-14-23(26)20-8-12-22(31-3)13-9-20/h5-14,24H,4,15-17H2,1-3H3,(H,27,28)/t24-/m0/s1 |
| XLogP | 4.9000 |
| ExactMass | 439.1817 |
| MonoisotopicMass | 439.1817 |
| TPSA | 86.0000 |
| Complexity | 532.0000 |
| Charge | 0.0000 |
| HBondDonorCount | 1 |
| HBondAcceptorCount | 5 |
| RotatableBondCount | 11 |
| HeavyAtomCount | 31 |
| IsotopeAtomCount | 0 |
| AtomStereoCount | 1 |
| DefinedAtomStereoCount | 1 |
| UndefinedAtomStereoCount | 0 |
| BondStereoCount | 0 |
| DefinedBondStereoCount | 0 |
| UndefinedBondStereoCount | 0 |
| CovalentUnitCount | 1 |
| PatentCount | 2120 |
| PatentFamilyCount | 517 |
| LiteratureCount | 207 |